Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ARQT: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ARQT
Arcutis Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ARQT
Arcutis Biotherapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 500d
Method
›
Moved together
LLY
with
ARQT
×0.48
co-movement · ARQT on LLY · 500d
r 0.29
scale to r 0.75
No shared co-movers.
LLY, solid
ARQT, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ARQT
Arcutis Biotherapeutics, Inc.
Change
25.55
▼
−5.38%
· post 25.56
Closed
Nov 6 '26
Mkt cap
$3.4B
Revenue
$144M
Q3 FY26
Revenue
$376M
FY25
vs
Compare
Closed
Nov 6 '26
LLY
ELI Lilly & Co
vs
ARQT
Arcutis Biotherapeutics, Inc.
1,360.90
▼
−0.28%
post 1,358.90
Price
25.55
▼
−5.38%
post 25.56
$1.2T
Mkt cap
$3.4B
Q3 FY26
$24.4B
Revenue
$144M
Q3 FY26
FY25
$65.2B
Revenue
$376M
FY25
Change
Change
LLY
1,360.90
▼
−0.28%
vs
ARQT
25.55
▼
−5.38%
Closed
Nov 6 '26